Skip to main content Skip to main navigation menu Skip to site footer

Evaluation of degeneration retinal ganglion cell loss in acute glaucoma model rats using syringe pump technique

  • Siti Hajar ,
  • Dessy Rakhmawati Emril ,
  • Nurwasis ,
  • Zinatul Hayati ,
  • Dedy Syahrizal ,

Abstract

Link of Video Abstract: https://youtu.be/vaGQXY-i4KE

 

Introduction: Glaucoma is a neurodegenerative disorder marked by the gradual decline in function and degeneration of the retinal ganglion cells (RGCs) and their axons. The elevated intraocular pressure (IOP) is a predominant contributing factor to its onset. Employing laboratory animals to model glaucoma is a well-established strategy that serves the dual purpose of identifying disease mechanisms and developing novel neuroprotective approaches. The aim of this study was to develop a preclinical acute model of glaucoma based on controllable intraocular pressure with a syringe pump in rat Rattus norvegicus.

Methods: This research was an animal-experimental study in animal model adult male Wistar rat (Rattus norvegicus), taken in May - October 2023 in an integrated laboratory Faculty of Veterinary Medicine Universitas Syiah Kuala. Total samples used in this research were 10 rats, divided into two categories which are control group (A) and treatment group (B) were given a pressure of 250 mmHg pressure in the right eye for 60 minutes. Apoptosis and degeneration of retinal ganglion cells after 8 weeks of elevated intraocular a pressure of 250 mmHg in the right eye for 60 minutes were observed by the HE staining.

 Result: A significant difference in IOP was noted between control group rat and treatment group rat. All rats that received treatment experienced an increase in IOP (100%). The RGC density decreased significantly in the treatment group rat (mean: 11.72 cell/field of view or lower 46.88%) compared with the control group (p =0.005).

Conclusion: A pressure of 250 mmHg for 60 minutes has been proven to cause degeneration of the RGCs up to nearly 50% within a week. We tried a technique to induce increased IOP in rats as a model of acute glaucoma. Syringe pump technique can effectively induce acute ocular hypertension in rats, which causes progressive loss of retinal ganglion cells.

References

  1. American Basic and Clinical Science Course. Basic and Clinical Science Course, Section 10. San Fransisco: 2018; p. 34–8.
  2. Stamper RL, Lieberman MF, Drake M V. Becker-Shaffer’s Diagnosis and Therapy of the Glaucoma: Eighth Edition. 2009.
  3. Boland MV, Ervin AM, Friedman DS, Jampel HD, Hawkins BS, Vollenweider D, et al. Comparative effectiveness of treatments for open-angle glaucoma: a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med. 2013;158(4):271-9.
  4. Vernazza S, Tirendi S, Passalacqua M, Piacente F, Scarfì S, Oddone F, et al. An innovative in vitro open-angle glaucoma model (IVOM) shows changes induced by increased ocular pressure and oxidative stress. Int J Mol Sci. 2021;22(22):12129.
  5. Wang H, Deng Y, Wan L, Huang L. A comprehensive map of disease networks and molecular drug discoveries for glaucoma. Sci Rep. 2020;10(1):1–13.
  6. Corredor RG, Goldberg JL. Retinal Ganglion cell life and death – mechanisms and implications for ophthalmology. Eur Ophthalmic Rev. 2009;03(02):109.
  7. Kersey JP, Broadway DC. Corticosteroid-induced glaucoma: a review of the literature. Eye (Lond). 2006;20(4):407-16.
  8. Benedict SR. A reagent for the detection of reducing sugars. J Biol Chem. 1909;5:485–7.
  9. Quigley H, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol. 2006;90(3):262–7.
  10. Tham YC, Li X, Wong TY, Quigley HA, Aung T, Cheng CY. Global prevalence of glaucoma and projections of glaucoma burden through 2040: A systematic review and meta-analysis. Ophthalmology. 2014;121(11):2081–90.
  11. Agostinone J, Alarcon-Martinez L, Gamlin C, Yu WQ, Wong ROL, Di Polo A. Insulin signalling promotes dendrite and synapse regeneration and restores circuit function after axonal injury. Brain. 2018;141(7):1963–80.
  12. Wang H, Deng Y, Wan L, Huang L. A comprehensive map of disease networks and molecular drug discoveries for glaucoma. Sci Rep. 2020;10(1):9719.
  13. Van Mechelen RJS, Wolters JE, Bertens CJF, Webers CAB, van den Biggelaar FJHM, Gorgels TGMF, et al. Animal models and drug candidates for use in glaucoma filtration surgery: A systematic review. Exp Eye Res. 2022;217:108972.
  14. Evangelho K, Mastronardi CA, de-la-Torre A. Experimental models of glaucoma: a powerful translational tool for the future development of new therapies for glaucoma in humans-A review of the literature. Medicina (Kaunas). 2019;55(6):280.
  15. Kersey JP, Broadway DC. Corticosteroid-induced glaucoma: A review of the literature. Eye. 2006;20(4):407–16.
  16. Sato K, Nishiguchi KM, Maruyama K, Moritoh S, Fujita K, Ikuta Y, et al. Topical ocular dexamethasone decreases intraocular pressure and body weight in rats. J Negat Results Biomed. 2016;15:5.
  17. Phulke S, Kaushik S, Kaur S, Pandav SS. Steroid-induced glaucoma: An avoidable irreversible blindness. J Curr Glaucoma Pract. 2017;11(2):67-72.
  18. Patel GC. Mechanisms of glucocorticoid-induced ocular hypertension and glaucoma. ProQuest Diss Theses. 2017;202. Available from: https://unthsc-ir.tdl.org/items/0878d5a6-426d-4c8c-ae05-fe84819d67b9.
  19. Skuta GL, Cantor LB WJ. Basic and Clinical Science Course, Section 10: Glaucoma. San Fransisco: American Academy Opthalmology.
  20. Chen J, Sun J, Yu H, Huang P, Zhong Y. Evaluation of the effectiveness of a chronic ocular hypertension mouse model induced by intracameral injection of cross-linking hydrogel. Front Med (Lausanne). 2021;8:643402.

How to Cite

Siti Hajar, Dessy Rakhmawati Emril, Nurwasis, Zinatul Hayati, & Dedy Syahrizal. (2023). Evaluation of degeneration retinal ganglion cell loss in acute glaucoma model rats using syringe pump technique. Bali Medical Journal, 13(1), 157–162. https://doi.org/10.15562/bmj.v13i1.4918

HTML
1

Total
0

Share